These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25538755)

  • 21. XRCC1 Arg399Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.
    Liu B; Shen T
    Tumour Biol; 2014 Jan; 35(1):507-12. PubMed ID: 24052436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population.
    Wu D; Jiang H; Gu Q; Zhang D; Li Z
    Tumour Biol; 2013 Oct; 34(5):3265-9. PubMed ID: 23780894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between the XRCC1 Arg399Gln polymorphism and risk of cancer: evidence from 297 case-control studies.
    Yi L; Xiao-Feng H; Yun-Tao L; Hao L; Ye S; Song-Tao Q
    PLoS One; 2013; 8(10):e78071. PubMed ID: 24205095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The XRCC1 Arg194Trp polymorphism is not a risk factor for glioma: A meta-analysis involving 1,440 cases and 2,562 controls.
    Zhang L; Wang Y; Qiu Z; Luo J; Zhou Z; Shu W
    Exp Ther Med; 2012 Dec; 4(6):1057-1062. PubMed ID: 23226774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between X-ray repair cross-complementing group 1 gene polymorphisms and glioma risk: a systematic review and meta-analysis based on 22 case-control studies.
    Li J; Chen Q; Liu B; Yang J; Shao L; Wu T
    Int J Clin Exp Med; 2015; 8(8):11863-80. PubMed ID: 26550099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis.
    Geng J; Zhang YW; Huang GC; Chen LB
    World J Gastroenterol; 2008 Nov; 14(43):6733-7. PubMed ID: 19034980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. XRCC1 Arg399Gln and Arg194Trp polymorphisms in childhood acute lymphoblastic leukemia risk: a meta-analysis.
    Wang R; Hu X; Zhou Y; Feng Q; Su L; Long J; Wei B
    Leuk Lymphoma; 2013 Jan; 54(1):153-9. PubMed ID: 22712837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis.
    Wei B; Zhou Y; Xu Z; Ruan J; Zhu M; Jin K; Zhou D; Hu Q; Wang Q; Wang Z; Yan Z
    Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):225-31. PubMed ID: 21647176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
    Saadat M; Ansari-Lari M
    Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An updated meta-analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk.
    Zhang XL; Lu Y; Yang S; Peng QL; Wang J; Xie L; Deng Y; He Y; Li TJ; Qin X; Li S
    Asian Pac J Cancer Prev; 2014; 15(7):3273-8. PubMed ID: 24815482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility: an updated meta-analysis.
    Pan Y; Zhao L; Chen XM; Gu Y; Shen JG; Liu LM
    Asian Pac J Cancer Prev; 2013; 14(10):5761-7. PubMed ID: 24289575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between XRCC1 gene polymorphisms and risk of glioma development: a meta-analysis.
    Sun JY; Zhang CY; Zhang ZJ; Dong YF; Zhang AL; Wang ZW; Mei XL
    Asian Pac J Cancer Prev; 2012; 13(9):4783-8. PubMed ID: 23167420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. XRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): a meta-analysis of case-control studies.
    Bao Y; Jiang L; Zhou JY; Zou JJ; Zheng JY; Chen XF; Liu ZM; Shi YQ
    PLoS One; 2013; 8(5):e64851. PubMed ID: 23717668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Arg399Gln polymorphism in the XRCC1 gene is associated with increased risk of hematological malignancies.
    Du L; Liu Y; Xue P; Song C; Shen J; He Q; Peng Y; Tong X; Tang L; Zhang Y
    Tumour Biol; 2015 Jun; 36(6):4545-54. PubMed ID: 25619474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. XRCC1 Arg399Gln gene polymorphism and the risk of systemic lupus erythematosus in the Polish population.
    Warchoł T; Mostowska A; Lianeri M; Lącki JK; Jagodziński PP
    DNA Cell Biol; 2012 Jan; 31(1):50-6. PubMed ID: 21682595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and risk of childhood acute lymphoblastic leukemia: a meta-analysis.
    Wang L; Yin F; Xu X; Hu X; Zhao D
    PLoS One; 2012; 7(4):e34897. PubMed ID: 22529951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma.
    Duell EJ; Holly EA; Bracci PM; Wiencke JK; Kelsey KT
    Cancer Res; 2002 Aug; 62(16):4630-6. PubMed ID: 12183419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. XRCC1 and XPD genetic polymorphisms and susceptibility to age-related cataract: a meta-analysis.
    Chi XX; Liu YY; Shi SN; Cong Z; Liang YQ; Zhang HJ
    Mol Vis; 2015; 21():335-46. PubMed ID: 25873778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. XRCC1 Arg280His polymorphism and glioma risk: A meta-analysis involving 1439 cases and 2564 controls.
    Zhang L; Wang Y; Qiu Z; Luo J; Zhou Z; Shu W
    Pak J Med Sci; 2013 Jan; 29(1):37-42. PubMed ID: 24353504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. X-ray repair cross-complementing group 1(XRCC1) genetic polymorphisms and thyroid carcinoma risk: a meta-analysis.
    Qian K; Liu KJ; Xu F; Chen XY; Chen GN; Yi WJ; Zhou EX; Tang ZH
    Asian Pac J Cancer Prev; 2012; 13(12):6385-90. PubMed ID: 23464463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.